Sequential Biotherapy Targeting IL-5 and IL-4/13 in Patients with Eosinophilic Asthma with Sinusitis and Otitis Media

Sequential Biotherapy Targeting IL-5 and IL-4/13 in Patients with Eosinophilic Asthma with Sinusitis and Otitis Media

Type 2 (T2) inflammation plays an important role in the pathogenesis of allergic diseases such as asthma, eosinophilic chronic rhinosinusitis (ECRS), or eosinophilic otitis media (EOM). Currently, in severe asthma with the T2 phenotype, biologics targeting mediators of T2 inflammation dramatically i...

Full description

Bibliographic Details
Main Authors:	Ayumi Chikumoto, Keiji Oishi, Kazuki Hamada, Tsunahiko Hirano, Tomoyuki Kakugawa, Keiko Kanesada, Kazuto Matsunaga
Format:	Article
Language:	English
Published:	MDPI AG 2022-03-01
Series:	Biomolecules
Subjects:	sequential biotherapy anti-IL-5 receptor antibody anti-IL-4/13 receptor monoclonal antibody multiple Type 2 inflammatory pathways eosinophil sinusitis eosinophilia otitis media
Online Access:	https://www.mdpi.com/2218-273X/12/4/522

Similar Items

Successful treatment of eosinophilic chronic rhinosinusitis and eosinophilic otitis media using the anti-IL-5 receptor monoclonal antibody benralizumab: A case report
by: Hiroki Kagoshima, et al.
Published: (2020-01-01)

The effect of anti-IL-6 receptor antibody for the treatment of McH-lpr/lpr-RA1 mice that spontaneously developed destructive arthritis and enthesitis
by: Takuya Izumiyama, et al.
Published: (2019-06-01)

DEVELOPMENTS OF RUSSIAN ORIGINAL BIOLOGICAL AGENTS FOR THE TREATMENT OF IMMUNOINFLAMMATORY RHEUMATIC DISEASES
by: E. L. Nasonov, et al.
Published: (2017-04-01)

A Genetic Association Test Accounting for Skewed X-Inactivation With Application to Biotherapy Immunogenicity in Patients With Autoimmune Diseases
by: Signe Hässler, et al.
Published: (2022-06-01)

Mini Review: New Treatments in Psoriatic Arthritis. Focus on the IL-23/17 Axis
by: Lazaros I. Sakkas, et al.
Published: (2019-08-01)

Anti-IL-6 Receptor Antibody Inhibits Spontaneous Pain at the Pre-onset of Experimental Autoimmune Encephalomyelitis in Mice
by: Kenichi Serizawa, et al.
Published: (2019-04-01)

Novel targeted inhibition of the IL-5 axis for drug reaction with eosinophilia and systemic symptoms syndrome
by: Limor Rubin, et al.
Published: (2023-04-01)

Features of severe asthma response to anti-IL5/IL5r therapies: identikit of clinical remission
by: Giovanna Elisiana Carpagnano, et al.
Published: (2024-01-01)

Efficacy and safety of levilimab in combination with methotrexate in subjects with rheumatoid arthritis: Results of phase II AURORA study
by: V. I. Mazurov, et al.
Published: (2021-05-01)

Efficacy and safety of levilimab in combination with methotrexate in patients with active rheumatoid arthritis: 56-week results of phase III randomized double-blind placebo-controlled trial SOLAR
by: V. I. Mazurov, et al.
Published: (2023-03-01)

Effectiveness and safety of levilimab in combination with methotrexate in treatment of patients with active rheumatoid arthritis resistant to methotrexate monotherapy (double-blinded randomized placebo controlled phase III clinical study SOLAR)
by: V. I. Mazurov, et al.
Published: (2021-08-01)

Takayasu’s Arteritis Diagnosed in an Adolescent Patient with Crohn’s Disease: Management of Biologicals
by: Kazuya Kishimoto, et al.
Published: (2021-09-01)

Anti-IL-17A antibody-associated de novo vitiligo: Case report and review of literature
by: Hsing-Jou Su, et al.
Published: (2023-01-01)

Domestic Parasitic Infections in Patients with Asthma and Eosinophilia in Germany – Three Cases with Learnings in the Era of Anti- IL5 Treatments
by: Barnikel M, et al.
Published: (2023-11-01)

A case of IgG4-related conjunctival tumor with severe systemic allergy treated with antibodies against cytokine receptors
by: Atsuki Fukushima, et al.
Published: (2022-06-01)

Domestic Parasitic Infections in Patients with Asthma and Eosinophilia in Germany – Three Cases with Learnings in the Era of Anti-IL5 Treatments [Letter]
by: Hanif MI, et al.
Published: (2023-12-01)

Immunogenicity to biological drugs in psoriasis and psoriatic arthritis
by: Fernando Valenzuela, et al.
Published: (2021-10-01)

Anti-IL5/IL5R Treatment in COPD: Should We Target Oral Corticosteroid-Dependent Patients?
by: Laroche J, et al.
Published: (2023-05-01)

A prospective study exploring the predictors of response to benralizumab in patients with refractory bronchial asthma
by: Masahiro Hirose, et al.
Published: (2022-02-01)

IL-6 receptor antibody treatment improves muscle weakness in experimental autoimmune myasthenia gravis mouse model
by: Shota Miyake, et al.
Published: (2024-05-01)

Generation and engineering of potent single domain antibody-based bispecific IL-18 mimetics resistant to IL-18BP decoy receptor inhibition
by: Britta Lipinski, et al.
Published: (2023-12-01)

IL-18 biology in severe asthma
by: Sarita Thawanaphong, et al.
Published: (2024-11-01)

Human and murine IL2 receptors differentially respond to the human-IL2 component of immunocytokines
by: Zulmarie Perez Horta, et al.
Published: (2019-06-01)

Corrigendum: Blockade of IL-33R/ST2 Signaling Attenuates Toxoplasma gondii Ileitis Depending on IL-22 Expression
by: Bernhard Ryffel, et al.
Published: (2020-10-01)

Emerging Role of Biologic Drugs Targeting IL-17 and IL-23: Pityriasis Rubra Pilaris
by: Luca Potestio, et al.
Published: (2024-07-01)

Linear IgA bullous dermatosis and elevated bullous interleukin‐6 levels: Responsive to treatment with Anti‐IL‐6 receptor monoclonals
by: Stanley C. Jordan, et al.
Published: (2023-02-01)

Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan
by: Yoshiya Tanaka, et al.
Published: (2019-03-01)

Corrigendum: IL-18 biology in severe asthma
by: Sarita Thawanaphong, et al.
Published: (2025-01-01)

Fasting induces IL-1 resistance and free fatty acid-mediated up-regulation of IL-1R2 and IL-1RA
by: jenifer j joesting, et al.
Published: (2014-07-01)

A Potential Role of IL-6/IL-6R in the Development and Management of Colon Cancer
by: Mimmo Turano, et al.
Published: (2021-04-01)

Decreased placental IL9 and IL9R in preeclampsia impair trophoblast cell proliferation, invasion, and angiogenesis
by: Yi Sun, et al.
Published: (2020-07-01)

Translatability of findings from cynomolgus monkey to human suggests a mechanistic role for IL-21 in promoting immunogenicity to an anti-PD-1/IL-21 mutein fusion protein
by: Mark A. Kroenke, et al.
Published: (2024-01-01)

IL-6 and IL-18 cytokine traps in COVID-19
by: A. A. Korotaeva, et al.
Published: (2024-07-01)

Corrigendum: Translatability of findings from cynomolgus monkey to human suggests a mechanistic role for IL-21 in promoting immunogenicity to an anti-PD-1/IL-21 mutein fusion protein
by: Mark A. Kroenke, et al.
Published: (2024-06-01)

Safety of interleukin inhibitors in patients with plaque psoriasis and history of neoplasms: a multicenter retrospective study – IL PSO (Italian landscape psoriasis)
by: Mario Valenti, et al.
Published: (2025-12-01)

Remission, low disease activity and improvement of pain and function in psoriatic arthritis patients treated with IL-12/23 and IL-17 inhibitors. A multicenter prospective study
by: F.M. Perrotta, et al.
Published: (2020-04-01)

Efficacy and safety of anti-interleukin-1 therapeutics in the treatment of knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials
by: Lizhi Yu, et al.
Published: (2023-02-01)

Improved antitumor effectiveness of oncolytic HSV-1 viruses engineered with IL-15/IL-15Rα complex combined with oncolytic HSV-1-aPD1 targets colon cancer
by: Zongfeng Hu, et al.
Published: (2024-10-01)

Biological behavior of Chrysomya putoria (Wiedemann, 1819) (Diptera: Calliphoridae) after refrigeration: Logistics for use in Biotherapy
by: DANIELE L. DALLAVECCHIA, et al.
Published: (2023-05-01)

Diagnostic Accuracy of IL-17A/IL-17F Gene Polymorphism and Anti-Carbamylated Protein Antibody for Rheumatoid Arthritis: Meta-analysis Study (2014-2020)
by: Samar Sayed Ahmed, et al.
Published: (2023-01-01)